๐ ๐บ๐ถ๐น๐ฒ๐๐๐ผ๐ป๐ฒ ๐ณ๐ผ๐ฟ ๐ณ๐น๐๐ผ๐ฟ๐ฒ๐๐ฐ๐ฒ๐ป๐ฐ๐ฒ-๐ด๐๐ถ๐ฑ๐ฒ๐ฑ ๐ฏ๐ฟ๐ฒ๐ฎ๐๐ ๐๐๐ฟ๐ด๐ฒ๐ฟ๐! ๐
๐๐ป๐ฑ๐ผ๐ฐ๐๐ฎ๐ป๐ถ๐ป๐ฒ ๐๐ฟ๐ฒ๐ฒ๐ป (๐๐๐) ๐ต๐ฎ๐ ๐ป๐ผ๐ ๐ผ๐ณ๐ณ๐ถ๐ฐ๐ถ๐ฎ๐น๐น๐ ๐ฏ๐ฒ๐ฒ๐ป ๐ฎ๐ฝ๐ฝ๐ฟ๐ผ๐๐ฒ๐ฑ ๐ฎ๐ ๐๐ฟ๐ฎ๐ฐ๐ฒ๐ฟ ๐ณ๐ผ๐ฟ ๐ฆ๐ฒ๐ป๐๐ถ๐ป๐ฒ๐น ๐๐๐บ๐ฝ๐ต ๐ก๐ผ๐ฑ๐ฒ ๐๐ถ๐ผ๐ฝ๐๐ (๐ฆ๐๐ก๐) ๐ถ๐ป ๐ฏ๐ฟ๐ฒ๐ฎ๐๐ ๐ฐ๐ฎ๐ป๐ฐ๐ฒ๐ฟ ๐ฎ๐ฐ๐ฟ๐ผ๐๐ ๐บ๐ผ๐๐ ๐ผ๐ณ ๐๐๐ฟ๐ผ๐ฝ๐ฒ.
Verdye (Indocyanine Green, ICG) has previously been approved for the breast SLN indication in Spain. Now this is extended to Austria, Belgium, Croatia, Czechia, Denmark, Finland, Greece, Hungary, Ireland, Italy, Netherlands, Poland, Portugal, Romania, Slovenia, Sweden and the UK.
This marks a major step forward for the clinical use of fluorescence-guided surgery.
๐ ๐ช๐ต๐ฎ๐ ๐ฑ๐ผ๐ฒ๐ ๐๐ต๐ถ๐ ๐บ๐ฒ๐ฎ๐ป ๐ณ๐ผ๐ฟ ๐๐๐ฟ๐ด๐ถ๐ฐ๐ฎ๐น ๐๐ฒ๐ฎ๐บ๐ ๐ฎ๐ป๐ฑ ๐๐ต๐ฒ๐ถ๐ฟ ๐ฝ๐ฎ๐๐ถ๐ฒ๐ป๐๐?
Where SLNB used to rely on radioactive tracers and blue dye, there is now a validated, patient-friendly alternative that fits into daily surgical practice.
Using 99mTc is a significant burden for both patients as well as hospitals which includes logistical challenges associated with pre-procedure administration and the risk of exposure to ionizing radiation. Additionally, blue dyes can pose significant potential risks including soft tissue necrosis, metabolic and hematologic side effects, making it infrequently utilised for routine surgical care.
With ICG fluorescence, SLNB becomes not just precise but also safer, more streamlined and more sustainable:
- Real-time visualisation
- Gentler for patients with no radiation and fewer side effect
- Greater autonomy in timing and logistics
- Lower environmental burden
- Backed by strong clinical evidence: non-inferior to technetium, superior to blue dye
This goes beyond a regulatory update. It reflects the growing evidence for ICG as a safe and practical choice that simplifies workflows and improves the patient experience.
The approval was supported by multiple meta-analyses studies which concluded that
- ICG-fluorescence (ICG-F) is superior to Blue Dye (BD)
- ICG-F is non-inferior to both radioisotope (RI)ย
- ICG-F is superior to both RI and RI+BDย
๐ Read the full press release by Diagnostic Green here.โ
๐ช๐ฒ ๐ฎ๐ฟ๐ฒ ๐ฝ๐ฟ๐ผ๐๐ฑ ๐๐ผ ๐๐๐ฎ๐ป๐ฑ ๐ฎ๐น๐ผ๐ป๐ด๐๐ถ๐ฑ๐ฒ ๐๐ต๐ฒ ๐๐๐ฟ๐ด๐ถ๐ฐ๐ฎ๐น ๐๐ฒ๐ฎ๐บ๐ ๐ฎ๐น๐ฟ๐ฒ๐ฎ๐ฑ๐ ๐น๐ฒ๐ฎ๐ฑ๐ถ๐ป๐ด ๐๐ต๐ถ๐ ๐๐ฟ๐ฎ๐ป๐๐ถ๐๐ถ๐ผ๐ป.
Their work is shaping the future of breast cancer surgery. Mobula continues to support surgical teams through each stage, from education to clinical adoption.ย
More and more hospitals are turning to fluorescence-guided SLNB as an efficient, and patient-friendly alternative to the traditional standard. Mobula supports this shift by offering a certified online training module on SLNB with ICG, developed in collaboration with the team of Annemiek Doeksen from St. Antonius Hospital and the GreenLight group of the LUMC.
Ready to get started? Our e-learning ‘Fluorescence-Guided Sentinel Lymph Node Biopsy’ is live.
๐ Curious what to expect? Watch the short preview video below and take your first step into fluorescence-guided surgery.
๐ Exploreย Mobula Academy training programme, or get in touch for tailored support.
Keep an eye on our website and LinkedIn to stay up to date about these exciting insights and innovations!